Clinical pharmacology of propranolol.
1975; Lippincott Williams & Wilkins; Volume: 52; Issue: 1 Linguagem: Inglês
10.1161/01.cir.52.1.6
ISSN1524-4539
Autores Tópico(s)Nitric Oxide and Endothelin Effects
ResumoHomeCirculationVol. 52, No. 1Clinical pharmacology of propranolol. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBClinical pharmacology of propranolol. A S Nies and D G Shand A S NiesA S Nies and D G ShandD G Shand Originally published1 Jul 1975https://doi.org/10.1161/01.CIR.52.1.6Circulation. 1975;52:6–15 eLetters(0) eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate. Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page. Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Mortlock R, Smith V, Nesci I, Bertoldi A, Ho A, El Mekkawi Z, Kakuzada L, Williams K, Pont L, De Rubis G and Dua K (2023) A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine, Chemico-Biological Interactions, 10.1016/j.cbi.2023.110351, 371, (110351), Online publication date: 1-Feb-2023. Comollo T, Zou X, Zhang C, Kesters D, Hof T, Sampson K and Kass R (2022) Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers, Channels, 10.1080/19336950.2022.2106025, 16:1, (173-184), Online publication date: 31-Dec-2022. Zhou J, Van der Heijden M, Salazar Leon L, Lin T, Miterko L, Kizek D, Perez R, Pavešković M, Brown A and Sillitoe R (2022) Propranolol Modulates Cerebellar Circuit Activity and Reduces Tremor, Cells, 10.3390/cells11233889, 11:23, (3889) Kim T, Kang J, An W and Sohn J (2022) Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow, Frontiers in Medicine, 10.3389/fmed.2022.973606, 9 Tsai C, Chen B, Chen H, Hsieh R, Lee J, Chu Y and Lu W (2022) Low-Dose Propranolol Prevents Functional Decline in Catecholamine-Induced Acute Heart Failure in Rats, Toxics, 10.3390/toxics10050238, 10:5, (238) Catoira-Boyle Y, WuDunn D, Cantor L, Lind J, Martin E and Gerber S (2022) Medical Management of Glaucoma Albert and Jakobiec's Principles and Practice of Ophthalmology, 10.1007/978-3-030-42634-7_176, (2331-2399), . Jovanović M, Petrović M, Cvijić S, Tomić N, Stojanović D, Ibrić S and Uskoković P (2021) 3D Printed Buccal Films for Prolonged-Release of Propranolol Hydrochloride: Development, Characterization and Bioavailability Prediction, Pharmaceutics, 10.3390/pharmaceutics13122143, 13:12, (2143) Prodel E, Cavalcanti T, Rocha H, Gondim M, Mira P, Fisher J and Nobrega A (2021) Sympathetic regulation of coronary circulation during handgrip exercise and isolated muscle metaboreflex activation in men, Experimental Physiology, 10.1113/EP089954, 106:12, (2400-2411), Online publication date: 1-Dec-2021. Kalam M, Rasool M, Alqahtani F, Imran I, Rehman A and Ahmed N (2021) Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients, Drug Design, Development and Therapy, 10.2147/DDDT.S297981, Volume 15, (1195-1211) Catoira-Boyle Y, WuDunn D, Cantor L, Lind J, Martin E and Gerber S (2020) Medical Management of Glaucoma Albert and Jakobiec's Principles and Practice of Ophthalmology, 10.1007/978-3-319-90495-5_176-1, (1-69), . Levine M and Brent J (2018) Beta Receptor Antagonists Critical Care Toxicology, 10.1007/978-3-319-20790-2_69-2, (1-16), . Hopkins L, Sunkersing J and Jacques A (2017) Too many pills to swallow: A case of a mixed overdose, Journal of the Intensive Care Society, 10.1177/1751143717693860, 18:3, (247-250), Online publication date: 1-Aug-2017. Liu G and McNally R (2017) Neutral mood induction during reconsolidation reduces accuracy, but not vividness and anxiety of emotional episodic memories, Journal of Behavior Therapy and Experimental Psychiatry, 10.1016/j.jbtep.2016.05.001, 54, (1-8), Online publication date: 1-Mar-2017. Levine M and Brent J (2017) Beta-Receptor Antagonists Critical Care Toxicology, 10.1007/978-3-319-17900-1_69, (771-786), . Tanabe H, Sahashi K, Kitano T, Tomita Y, Saito A and Hirose H (2015) Effects of Oral Propranolol on a Juxtapapillary Capillary Hemangioma: A Single-Subject Pilot Study, Ophthalmic Surgery, Lasers and Imaging Retina, 10.3928/23258160-20150323-15, 46:3, (380-383), Online publication date: 1-Mar-2015. Levine M and Brent J (2015) Beta Receptor Antagonists Critical Care Toxicology, 10.1007/978-3-319-20790-2_69-1, (1-16), . Taegtmeyer A, Haschke M, Tchambaz L, Buylaert M, Tschöpl M, Beuers U, Drewe J, Krähenbühl S and Aspichueta P (2014) A Study of the Relationship between Serum Bile Acids and Propranolol Pharmacokinetics and Pharmacodynamics in Patients with Liver Cirrhosis and in Healthy Controls, PLoS ONE, 10.1371/journal.pone.0097885, 9:6, (e97885) Filippi L, Cavallaro G, Fiorini P, Malvagia S, Della Bona M, Giocaliere E, Bagnoli P, Dal Monte M, Mosca F, Donzelli G and la Marca G (2013) Propranolol concentrations after oral administration in term and preterm neonates, The Journal of Maternal-Fetal & Neonatal Medicine, 10.3109/14767058.2012.755169, 26:8, (833-840), Online publication date: 1-May-2013. Brooks D, Levine M, O'Connor A, French R and Curry S (2011) Toxicology in the ICU, Chest, 10.1378/chest.10-2726, 140:4, (1072-1085), Online publication date: 1-Oct-2011. Cushing S, Boucek R, Manning S, Sidbury R and Perkins J (2010) Initial Experience With a Multidisciplinary Strategy for Initiation of Propranolol Therapy for Infantile Hemangiomas, Otolaryngology–Head and Neck Surgery, 10.1177/0194599810390445, 144:1, (78-84), Online publication date: 1-Jan-2011. Royster R, Groban L, Grosshans D, Jones-Haywood M and Slaughter T (2011) Cardiovascular Pharmacology Kaplan's Cardiac Anesthesia: The Echo Era, 10.1016/B978-1-4377-1617-7.00010-8, (235-295), . Wang Y, Zuo Z, Chen X, Tomlinson B and Chow M (2010) Improving sublingual delivery of weak base compounds using pHmax concept: Application to propranolol, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2009.12.011, 39:4, (272-278), Online publication date: 1-Feb-2010. Shimizudani T, Nagaoka K, Hanioka N, Yamano S and Narimatsu S (2010) Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys, Chemico-Biological Interactions, 10.1016/j.cbi.2009.10.007, 183:1, (67-78), Online publication date: 1-Jan-2010. Coté C, Lerman J, Ward R, Lugo R and Goudsouzian N (2009) Pharmacokinetics and Pharmacology of Drugs Used in Children A Practice of Anesthesia for Infants and Children, 10.1016/B978-141603134-5.50010-X, (89-146), . Zubidat A, Nelson R and Haim A (2008) Urinary adrenalin and cortisol secretion patterns of social voles in response to adrenergic blockade under basal conditions, Physiology & Behavior, 10.1016/j.physbeh.2007.08.024, 93:1-2, (243-249), Online publication date: 1-Jan-2008. Cantor L, WuDunn D, Gerber S, Catoira Y and Allen R (2008) Medical Management of Glaucoma Albert &Jakobiec's Principles &Practice of Ophthalmology, 10.1016/B978-1-4160-0016-7.50220-4, (2763-2801), . Eldadah B, Pechnik S, Holmes C, Moak J, Saleem A and Goldstein D (2006) Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope, Clinical Science, 10.1042/CS20060017, 111:3, (209-216), Online publication date: 1-Sep-2006. Ward R and Lugo R (2005) Cardiovascular Drugs for the Newborn, Clinics in Perinatology, 10.1016/j.clp.2005.09.013, 32:4, (979-997), Online publication date: 1-Dec-2005. Santhi R and Worthley L (2003) Hypertension in the Critically Ill Patient, Critical Care and Resuscitation, 10.1016/S1441-2772(23)01215-2, 5:1, (24-42), Online publication date: 1-Mar-2003. Bessho R and Chambers D (2002) Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat, The Journal of Thoracic and Cardiovascular Surgery, 10.1067/mtc.2002.121976, 124:2, (340-351), Online publication date: 1-Aug-2002. Dı́az-Cabiale Z, Cordón M, Coveñas R, Rivera A, Yanaihara N, Fuxe K, González-Barón S and Narváez J (2002) Propranolol blocks the tachycardia induced by galanin (1–15) but not by galanin (1–29), Regulatory Peptides, 10.1016/S0167-0115(02)00060-5, 107:1-3, (29-36), Online publication date: 1-Jul-2002. Bessho R and Chambers D (2001) Myocardial protection: The efficacy of an ultra-short-acting β-blocker, esmolol, as a cardioplegic agent, The Journal of Thoracic and Cardiovascular Surgery, 10.1067/mtc.2001.115919, 122:5, (993-1003), Online publication date: 1-Nov-2001. Zvara D (2016) Treatment of Perioperative Myocardial Ischemia, Seminars in Cardiothoracic and Vascular Anesthesia, 10.1053/scva.2001.23719, 5:2, (166-183), Online publication date: 1-Jul-2001. Prichard B, Owens C and Graham B (2000) ��-Receptor Blocking Agents Ullmann's Encyclopedia of Industrial Chemistry, 10.1002/14356007.a22_665 Scriabine A and Taylor D (2000) Antihypertensives Ullmann's Encyclopedia of Industrial Chemistry, 10.1002/14356007.a04_235 Hoste A and Sys S (1998) Ca2+ Channel-Blocking Activity of Propranolol and Betaxolol in Isolated Bovine Retinal Microartery, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199809000-00009, 32:3, (390-396), Online publication date: 1-Sep-1998. Kerns W, Ransom M, Tomaszewski C and Raymond R (2008) The Effect of Hypertonic Sodium and Dantrolene on Propranolol Cardiotoxicity, Academic Emergency Medicine, 10.1111/j.1553-2712.1997.tb03576.x, 4:6, (545-551), Online publication date: 1-Jun-1997. Kerns W, Schroeder‡ D, Williams‡ C, Tomaszewski C and Raymond R (1997) Insulin Improves Survival in a Canine Model of Acute β-Blocker Toxicity, Annals of Emergency Medicine, 10.1016/S0196-0644(97)70196-3, 29:6, (748-757), Online publication date: 1-Jun-1997. Narimatsu S, Mochida M, Matsumoto T, Masubuchi Y, Horie T, Nagata K, Funae Y, Cho A and Suzuki T (1996) Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats, Chemico-Biological Interactions, 10.1016/0009-2797(96)03726-X, 101:3, (207-224), Online publication date: 1-Sep-1996. MUIR W, SAMŚ R and SCHALL S (2008) Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4′‐hydroxypropranolol in dogs, Journal of Veterinary Pharmacology and Therapeutics, 10.1111/j.1365-2885.1996.tb00047.x, 19:4, (259-267), Online publication date: 1-Aug-1996. STAUBER R, HEINEMANN A, TRAUNER M and KREJS G (2008) Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats, European Journal of Clinical Investigation, 10.1111/j.1365-2362.1996.tb02152.x, 26:8, (676-680), Online publication date: 1-Aug-1996. Stauber R, Trauner M, Heinemann A and Stark G (2011) High-dose propranolol attenuates pressor responses to norepinephrine in mesenteric arterial beds of rats, International Journal of Angiology, 10.1007/BF02043503, 4:01, (31-33) LIN H, TSAI Y, YANG M, HOU M, LEE F, CHEN L and LEE S (2008) Haemodynamic effects of a combination of propranolol and clonidine in patients with post‐hepatitic cirrhosis, Journal of Gastroenterology and Hepatology, 10.1111/j.1440-1746.1995.tb01094.x, 10:3, (281-286), Online publication date: 1-Jun-1995. Westerlind A, Larsson L, Häggendal J and Ekström‐Jodal B (2008) Effects of arterial hypoxia and β‐adrenoceptor blockade on cerebral blood flow and oxygen uptake following E. coli endotoxin in dogs , Acta Anaesthesiologica Scandinavica, 10.1111/j.1399-6576.1995.tb04102.x, 39:4, (472-478), Online publication date: 1-May-1995. Kerns W, Kline J and Ford M (1994) β-Blocker and Calcium Channel Blocker Toxicity, Emergency Medicine Clinics of North America, 10.1016/S0733-8627(20)30433-8, 12:2, (365-390), Online publication date: 1-May-1994. O'Connell A, Van Wuyckhuyse B, Pearson S and Bowen W (1993) The effect of propranolol on salivary gland function and dental caries development in young and aged rats, Archives of Oral Biology, 10.1016/0003-9969(93)90094-3, 38:10, (853-861), Online publication date: 1-Oct-1993. Spahn D, Frasco P, White W, Smith L, McRae R and Leone B (1993) Is esmolol cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis, Journal of the American College of Cardiology, 10.1016/0735-1097(93)90115-H, 21:3, (809-821), Online publication date: 1-Mar-1993. Williams R, Goyle K, Herman T, Rofman B, Ruoff G and Hogan L (2013) Dose‐Dependent Effects of Betaxolol in Hypertension: A Double‐Blind, Multicenter Study, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1992.tb03848.x, 32:4, (360-367), Online publication date: 1-Apr-1992. Labow R, Desjardins S and Keon W (1991) Validation of a human atrial trabecular preparation for evaluation of inotropic substances, Journal of Pharmacological Methods, 10.1016/0160-5402(91)90036-5, 26:4, (257-268), Online publication date: 1-Dec-1991. Westerlind A, Larsson L, Häggendal J and Ekström‐Jodal B (2008) Prevention of endotoxin‐induced increase of cerebral oxygen consumption in dogs by propranolol pretreatment, Acta Anaesthesiologica Scandinavica, 10.1111/j.1399-6576.1991.tb03383.x, 35:8, (745-749), Online publication date: 1-Nov-1991. Perret G, Yin Y, Nicolas P, Vassy R, Uzzan B and Louchahi M (2009) In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5'‐deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol , Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.1991.tb00747.x, 5:7, (583-593), Online publication date: 1-Oct-1991. Cao A, Hantz-Brachet E, Azize B, Taillandier E and Perret G (1991) The interaction of d-propranolol and dimyristoyl phosphatidylcholine large unilamellar vesicles investigated by quasielastic light scattering and Fourier-transform infrared spectroscopy, Chemistry and Physics of Lipids, 10.1016/0009-3084(91)90096-T, 58:3, (225-232), Online publication date: 1-Jul-1991. Katyare S and Rajan R (1991) Altered energy coupling in rat heart mitochondria following in vivo treatment with propranolol, Biochemical Pharmacology, 10.1016/0006-2952(91)90325-Y, 42:3, (617-623), Online publication date: 1-Jul-1991. Shinoda T, Smith C, Khairallah P, Fouad-Tarazi F and Estafanous F (1991) Effects of propranolol on myocardial performance during acute normovolemic hemodilution, Journal of Cardiothoracic and Vascular Anesthesia, 10.1016/1053-0770(91)90087-A, 5:1, (15-22), Online publication date: 1-Feb-1991. Gerber S, Cantor L and Brater D (1990) Systemic drug interactions with topical glaucoma medications, Survey of Ophthalmology, 10.1016/0039-6257(90)90090-I, 35:3, (205-218), Online publication date: 1-Nov-1990. Cortelli P (2016) Letter to the Editor, Cephalalgia, 10.1046/j.1468-2982.1990.1003153.x, 10:3, (153-153), Online publication date: 1-Jun-1990. Maxwell R and Eckhardt S (1990) Propranolol Drug Discovery, 10.1007/978-1-4612-0469-5_1, (3-18), . Stark G, Stark U, Lueger A, Bertuch H, Pilger E, Pietsch B, Tritthart H and Lindner W (1989) The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts, Basic Research in Cardiology, 10.1007/BF01908198, 84:5, (461-468), Online publication date: 1-Sep-1989. TRNOVEC T and KÁLLAY Z (1989) Clinical Pharmacokinetics of Beta-Blockers Determination of Beta-Blockers in Biological Material, 10.1016/B978-0-444-87305-7.50008-6, (23-74), . Fahmy N, Bottros M, Charchaflieh J, Matta E and Sunder N (1989) A randomized comparison of labetalol and nitroprusside for induced hypotension, Journal of Clinical Anesthesia, 10.1016/0952-8180(89)90002-0, 1:6, (409-413), Online publication date: 1-Jan-1989. Prichard B (1989) Beta adrenoceptor blocking drugs Electrocardiography and Cardiac Drug Therapy, 10.1007/978-94-009-1081-2_22, (298-322), . Eldon M, Kinkel A, Daniel J and Latts J (2006) Bioavailability of propranolol hydrochloride tablet formulations: Application of multiple dose crossover studies, Biopharmaceutics & Drug Disposition, 10.1002/bdd.2510100108, 10:1, (69-76), Online publication date: 1-Jan-1989. Ochs H, Bahrmann H, Greenblatt D and Labedzki L (2013) Pharmacodynamic Comparison of l ‐Bunolol with Propranolol, Metoprolol, and Placebo , The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1988.tb05723.x, 28:12, (1101-1105), Online publication date: 1-Dec-1988. Barazzone C, Jaccard C, Berner M, Dayer P, Rouge J, Oberhansli I and Friedli B (1988) Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair., Heart, 10.1136/hrt.60.2.156, 60:2, (156-161), Online publication date: 1-Aug-1988. Kirkorian G, Touboul P and Atallah G (1988) Electrophysiologic effects of propranolol in intraventricular conduction disturbance, The American Journal of Cardiology, 10.1016/0002-9149(88)90941-1, 61:4, (341-345), Online publication date: 1-Feb-1988. Dunn J (2013) Controlled‐Release Formulations of Propranolol and Verapamil, The Journal of Clinical Pharmacology, 10.1177/009127008702700104, 27:1, (22-31), Online publication date: 1-Jan-1987. Veronee C, Lewis W, Takla M, Hull-Ryde E and Lowe J (1986) Protective metabolic effects of propranolol during total myocardial ischemia, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(19)35796-4, 92:3, (425-433), Online publication date: 1-Sep-1986. Sokoloff N, Spielman S, Greenspan A, Rae A, Stephen Porter R, Lowenthal D, Hakki A, Iskandrian A, Kay H and Horowitz L (1986) Plasma norepinephrine in exercise-induced ventricular tachycardia, Journal of the American College of Cardiology, 10.1016/S0735-1097(86)80085-7, 8:1, (11-17), Online publication date: 1-Jul-1986. Kern M, Miller J and Henry R (1986) Dose-related effects of intracoronary nitroglycerin on coronary hyperemia in patients with coronary artery disease, American Heart Journal, 10.1016/0002-8703(86)90632-0, 111:5, (845-852), Online publication date: 1-May-1986. Nestico P and Morganroth J (1986) The Pharmacology of Antiarrhythmic Drugs The Pathophysiology and Pharmacotherapy of Myocardial Infarction, 10.1016/B978-0-12-238045-7.50013-3, (241-268), . Kern M and Miller J (1986) Coronary spasm, steal, and stenosis: Implications for management of ischemic heart disease, Current Problems in Cardiology, 10.1016/0146-2806(86)90014-9, 11:1, (5-67), Online publication date: 1-Jan-1986. Hennis P (1986) Preoperative Medication: Maintenance or Modification Cardiac Anaesthesia: Problems and Innovations, 10.1007/978-94-009-4265-3_4, (26-37), . Kirshenbaum J, Kloner R, Antman E and Braunwald E (1985) Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia., Circulation, 72:4, (873-880), Online publication date: 1-Oct-1985. Kern M, Horowitz J, Ganz P, Gaspar J, Colucci W, Lorell B, Barry W and Mudge G (1985) Attenuation of coronary vascular resistance by selective alpha1,-adrenergic blockade in patients with coronary artery disease, Journal of the American College of Cardiology, 10.1016/S0735-1097(85)80421-6, 5:4, (840-846), Online publication date: 1-Apr-1985. Spence P, Weisel R, Easdown J, Jabr A, Yap V and Salerno T (1985) The Hemodynamic Effects and Mechanism of Action of Pulmonary Artery Balloon Counterpulsation in the Treatment of Right Ventricular Failure during Left Heart Bypass, The Annals of Thoracic Surgery, 10.1016/S0003-4975(10)62625-2, 39:4, (329-335), Online publication date: 1-Apr-1985. Spence P, Weisel R, Easdown J, Jabr K and Salerno T (1985) Pulmonary artery balloon counterpulsation in the management of right heart failure during left heart bypass, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(19)38822-1, 89:2, (264-268), Online publication date: 1-Feb-1985. Yeh S, Lin F, Chou Y, Hung J and Wu D (1985) Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol., Circulation, 71:1, (104-109), Online publication date: 1-Jan-1985. Prichard B (1985) β-Adrenoceptor Blocking Agents Clinical Pharmacology of Antianginal Drugs, 10.1007/978-3-642-69524-7_12, (385-458), . Chatterjee K and Parmley W (1985) Therapy of Acute Myocardial Infarction Diagnosis and Therapy of Coronary Artery Disease, 10.1007/978-1-4613-2569-7_13, (357-402), . Tamai G, Morita I, Masujima T, Imai H and Yoshida H (1984) Direct, Simultaneous Determination of Propranolol and Its 4-Hydroxy Metabolite by Liquid Chromatography, Journal of Pharmaceutical Sciences, 10.1002/jps.2600731243, 73:12, (1825-1827), Online publication date: 1-Dec-1984. Nestico P, DePace N and Morganroth J (1984) Therapy with Conventional Antiarrhythmic Drugs for Ventricular Arrhythmias, Medical Clinics of North America, 10.1016/S0025-7125(16)31096-3, 68:5, (1295-1319), Online publication date: 1-Nov-1984. Ali F, Sarper R, Malveaux E and Farajx B (1984) Preparation and Biodistribution of 99mTc-Labeled Tyramine Iminodiacetic Acid, Journal of Pharmaceutical Sciences, 10.1002/jps.2600731009, 73:10, (1363-1365), Online publication date: 1-Oct-1984. Svedenhag J, Henriksson J and Juhlin-Dannfelt A (1984) Beta-adrenergic blockade and training in human subjects: effects on muscle metabolic capacity, American Journal of Physiology-Endocrinology and Metabolism, 10.1152/ajpendo.1984.247.3.E305, 247:3, (E305-E311), Online publication date: 1-Sep-1984. Vlietstra R and McGoon M (2016) Beta-adrenergic blockers, Postgraduate Medicine, 10.1080/00325481.1984.11698714, 76:3, (71-80), Online publication date: 1-Sep-1984. Trung A, Sirois G, Dubé L and McGilveray I (2006) Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma, Biopharmaceutics & Drug Disposition, 10.1002/bdd.2510050310, 5:3, (281-290), Online publication date: 1-Jul-1984. Frishman W, Furberg C and Friedewald W (1984) The use of β-adrenergic blocking drugs in patients with myocardial infarction, Current Problems in Cardiology, 10.1016/0146-2806(84)90015-X, 9:3, (3-50), Online publication date: 1-Jun-1984. Bai S and Abramson F (1984) Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog, Journal of Pharmacokinetics and Biopharmaceutics, 10.1007/BF01061724, 12:3, (333-349), Online publication date: 1-Jun-1984. Wei J, Spotnitz H, Spotnitz W, Benvenisty A, Haasler G, Malm J and Hoffman B (1984) Pharmacologic antagonism of propranolol in dogs, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(19)38456-9, 87:5, (732-742), Online publication date: 1-May-1984. Bercoff E, Bataille C, Pariente A, Valla D, Delhotal B and Lebrec D (1984) Assessment of βrenergic Blockade with Propranolol in Patients with Cirrhosis, Hepatology, 10.1002/hep.1840040317, 4:3, (451-453), Online publication date: 1-May-1984. Jensen O (2011) Fetal Heart Rate Response to a Controlled Sound Stimulus After Propranolol Administration to the Mother, Acta Obstetricia et Gynecologica Scandinavica, 10.3109/00016348409155496, 63:3, (199-202), Online publication date: 1-Jan-1984. SVEDENHAG J, HENRIKSSON J, JUHLIN‐DANNFELT A and ASANO K (2008) Beta‐adrenergic blockade and training in healthy men—effects on central circulation, Acta Physiologica Scandinavica, 10.1111/j.1748-1716.1984.tb07376.x, 120:1, (77-86), Online publication date: 1-Jan-1984. Caldwell J, Frade P, Reddy P, Mayer J and Kelly A (1984) An evaluation of a new patient compliance index using plasma propranolol levels, Journal of Chronic Diseases, 10.1016/0021-9681(84)90037-7, 37:9-10, (689-698), Online publication date: 1-Jan-1984. Rosenthal J (1984) Antihypertensive Therapie Arterielle Hypertonie, 10.1007/978-3-662-00760-0_36, (687-737), . Kilfeather S, Massarella A, Turner P and Findley L (1984) Beta-adrenoceptor involvement in tremor production: possible defects in essential tremor Movement Disorders: Tremor, 10.1007/978-1-349-06757-2_16, (225-244), . Globus M, Keren A, Eldad M, Granot C, Tzivoni D, Lavy S and Stern S (1983) The effect of chronic propranolol therapy on regional cerebral blood flow in hypertensive patients., Stroke, 14:6, (964-967), Online publication date: 1-Nov-1983. Kendall M and John V (1983) Oxprenolol: Clinical pharmacology, pharmacokinetics, and pharmacodynamics, The American Journal of Cardiology, 10.1016/0002-9149(83)90639-2, 52:9, (D27-D33), Online publication date: 1-Nov-1983. Hung J, Lamb I, Connolly S, Jutzy K, Goris M and Schroeder J (1983) The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study., Circulation, 68:3, (560-567), Online publication date: 1-Sep-1983. Silberx B, Holford N and Riegelman S (1983) Dose-Dependent Elimination of Propranolol and its Major Metabolites in Humans, Journal of Pharmaceutical Sciences, 10.1002/jps.2600720703, 72:7, (725-732), Online publication date: 1-Jul-1983. Kern M, Ganz P, Horowitz J, Gaspar J, Barry W, Lorell B, Grossman W and Mudge G (1983) Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease., Circulation, 67:6, (1178-1185), Online publication date: 1-Jun-1983. Sheehan M, Brammell H, Sable D, Nies A and Horwitz L (1983) Effect of beta-adrenergic blockade on circulating catecholamines and dopamine-beta-hydroxylase activity during exercise in normal subjects, American Heart Journal, 10.1016/0002-8703(83)90240-5, 105:5, (777-782), Online publication date: 1-May-1983. Baldrati A, Cortelli P, Procaccianti G, Gamberini G, D'Alessandro R, Baruzzi A and Sacquegna T (1983) Propranolol and acetylsalicylic acid in migraine prophylaxis, Acta Neurologica Scandinavica, 10.1111/j.1600-0404.1983.tb04561.x, 67:3, (181-186), Online publication date: 1-Mar-1983. Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T and Kushida K (1983) Concentration-effect and time-effect relationships of carteolol, European Journal of Clinical Pharmacology, 10.1007/BF00542514, 25:6, (749-757), . Fechter P, Ha H, Follath F and Nager F (1983) The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias, European Journal of Clinical Pharmacology, 10.1007/BF00542510, 25:6, (729-734), . White R and Rubin A (1983) Blood Pressure Control in Chronic Dialysis Patients Replacement of Renal Function by Dialysis, 10.1007/978-94-009-6768-7_28, (575-587), . Boyden P and Wit A (1983) Pharmacology of the antiarrhythmic drugs Cardiac therapy, 10.1007/978-1-4613-3855-0_7, (171-234), . Larsen T and Teräväinen H (2009) Propranolol and essential tremor: Rôle of the membrane effect, Acta Neurologica Scandinavica, 10.1111/j.1600-0404.1982.tb06847.x, 66:3, (289-294) Goosby E and Goldschlager N (2016) Medical management of angina, Postgraduate Medicine, 10.1080/00325481.1982.11716181, 72:3, (50-67), Online publication date: 1-Sep-1982. Zaroslinski J, Borgman R, O'Donnell J, Anderson W, Erhardt P, Kam S, Reynolds R, Lee R and Gorczynski R (1982) Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient, Life Sciences, 10.1016/0024-3205(82)90547-1, 31:9, (899-907), Online publication date: 1-Aug-1982. Golightly L (2012) Pindolol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses, and Adverse Effects, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1982.tb04521.x, 2:3, (134-147), Online publication date: 6-May-1982. Sklar J, Johnston G, Overlie P, Gerber J, Brammell H, Gal J and Nies A (1982) The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men., Circulation, 65:5, (894-899), Online publication date: 1-May-1982. Ochs H, Grube E, Greenblatt D, Knüchel M and Bodem G (1982) Kinetics and cardiac effects of propranolol in humansPharmakodynamische und pharmakokinetische Untersuchungen mit Propranolol, Klinische Wochenschrift, 10.1007/BF01756098, 60:10, (521-525), Online publication date: 1-May-1982. Sable D, Brammell H, Sheehan M, Nies A, Gerber J and Horwitz L (1982) Attenuation of exercise conditioning by beta-adrenergic blockade., Circulation, 65:4, (679-684), Online publication date: 1-Apr-1982. CHAMBERS J, PITTMAN C and SUDA A (2013) The Effects of Propranolol on Thyroxine Metabolism and Triiodothyronines Production in Man, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1982.tb02657.x, 22:2-3, (110-116), Online publication date: 3-Feb-1982. Lappas D (1982) The Anaesthetic Management of Coronary and Cardiac Surgery Inhalation Anaesthesia Today and Tomorrow, 10.1007/978-3-662-39944-6_11, (87-95), . Lydtin H and Lohmöller G (1982) β-Receptorenblocker Herzkrankheiten, 10.1007/978-3-642-96617-0_31, (753-776), . Lappas D (1982)
Referência(s)